> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Renews Cardiovascular and Renal Drugs Advisory Panel
- URL: https://www.fdaweb.com/fda-renews-cardiovascular-and-renal-drugs-advisory-panel/
- Published: 2016-09-01T12:00:00.000Z
- Updated: 2026-09-14T21:28:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136686

*Federal Register* Notice: The FDA commissioner is renewing the Cardiovascular and Renal Drugs Advisory Committee for an additional two years beyond the charter expiration date. The new charter will be in effect until 8/27/18\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-09-01/pdf/2016-21041.pdf?ref=fdaweb.com)